Annual SG&A
$344.34M$1.01M+0.30%
Summary
- Current Value
- As of today, TXG annual SG&A is $344.34M, up +0.30% on
- Historical Performance
- TXG annual SG&A is up +33.69% over the past 3 years, and up +163.19% over the past 5 years
- All-Time High Comparison
- TXG annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- TXG annual SG&A is +15.44% above its 3-year low of $298.30M reached on an earlier date
- Sector Comparison
- TXG annual SG&A is higher than 93.07% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $344.34M | +0.3% | +33.7% | +163.2% | +636.8% | |
| Quarterly SG&A | $75.36M | -7.8% | +2.7% | +46.2% | – | |
| TTM SG&A | -$5.93B | -1861.4% | -2149.7% | -3303.3% | – | |
| Price | $19.99 | +28.7% | -47.1% | -87.4% | – | |
| Annual Operating Expenses | $609.04M | -0.8% | +29.8% | +184.7% | +671.9% | |
| Annual Operating Profit | -$194.56M | +4.8% | -267.7% | -569.3% | -958.8% | |
| Annual D&A | $43.71M | +0.2% | +54.7% | +518.6% | +915.3% | |
| Annual Revenue | $610.79M | -1.3% | +24.5% | +148.4% | +759.2% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $344.34M | at high | |
| 5Y | $344.34M | at high | |
| All | $344.34M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $298.30M | N/A | +15.4% |
| 5Y | $202.33M | N/A | +70.2% |
| All | $46.74M | +636.8% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $344.34M | +0.3% | |
| $343.33M | +15.1% | |
| $298.30M | +15.8% | |
| $257.56M | +27.3% |
| Year | Value | Change |
|---|---|---|
| $202.33M | +54.6% | |
| $130.83M | +48.8% | |
| $87.94M | +88.2% | |
| $46.74M | - |
FAQ
What is the current annual SG&A of TXG?
As of today, TXG annual SG&A is $344.34M
What is 1-year change in TXG annual SG&A?
TXG annual SG&A is up +0.30% year-over-year
What is 3-year change in TXG annual SG&A?
TXG annual SG&A is up +33.69% over the past 3 years
How far is TXG annual SG&A from its all-time high?
TXG annual SG&A is currently at its all-time high
How does TXG annual SG&A rank versus sector peers?
TXG annual SG&A is higher than 93.07% of companies in Healthcare sector
When is TXG next annual earnings release?
The next annual earnings release for TXG is on
Quarterly SG&A
$75.36M$921.00K+1.24%
Summary
- Current Value
- As of today, TXG quarterly SG&A is $75.36M, up +1.24% on
- Historical Performance
- TXG quarterly SG&A is down -7.77% year-over-year, and up +2.66% over the past 3 years
- All-Time High Comparison
- TXG quarterly SG&A is currently -19.69% below its historical high of $93.83M set on
- 3-Year Low Comparison
- TXG quarterly SG&A is +1.24% above its 3-year low of $74.43M reached on
- Sector Comparison
- TXG quarterly SG&A is higher than 89.39% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $75.36M | +1.2% | -7.8% | +2.7% | +46.2% | |
| Annual SG&A | $344.34M | – | +0.3% | +33.7% | +163.2% | |
| TTM SG&A | -$5.93B | -1845.6% | -1861.4% | -2149.7% | -3303.3% | |
| Price | $19.99 | +72.3% | +28.7% | -47.1% | -87.4% | |
| Quarterly Operating Expenses | $133.13M | -3.3% | -9.4% | -1.0% | +63.0% | |
| Quarterly Operating Profit | -$32.24M | -204.9% | +22.3% | +19.4% | -32.8% | |
| Quarterly D&A | $12.25M | +26.9% | +14.0% | +51.0% | +151.2% | |
| Quarterly Revenue | $149.00M | -13.8% | -1.8% | +13.7% | +107.5% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $93.83M | N/A | -19.7% |
| 3Y | $93.83M | -19.7% | |
| 5Y | $93.83M | -19.7% | |
| All | $93.83M | -19.7% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $74.43M | +1.2% | |
| 3Y | $74.43M | +1.2% | |
| 5Y | $55.97M | N/A | +34.6% |
| All | $8.92M | +744.8% |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of TXG?
As of today, TXG quarterly SG&A is $75.36M
What is TXG quarterly SG&A most recent change?
TXG quarterly SG&A was up +1.24% on September 30, 2025
What is 1-year change in TXG quarterly SG&A?
TXG quarterly SG&A is down -7.77% year-over-year
How far is TXG quarterly SG&A from its all-time high?
TXG quarterly SG&A is currently -19.69% below its historical high of $93.83M set on December 31, 2024
How does TXG quarterly SG&A rank versus sector peers?
TXG quarterly SG&A is higher than 89.39% of companies in Healthcare sector
When is TXG next earnings release?
The next earnings release for TXG is on
TTM SG&A
-$5.93B$76.32M-1.30%
Summary
- Current Value
- As of today, TXG TTM SG&A is -$5.93B, down -1.30% on
- Historical Performance
- TXG TTM SG&A is down -1861.41% year-over-year, and down -2149.71% over the past 3 years
- All-Time High Comparison
- TXG TTM SG&A is currently -775.28% below its historical high of $878.10M set on an earlier date
- 3-Year Low Comparison
- TXG TTM SG&A is at its 3-year low
- Sector Comparison
- TXG TTM SG&A is higher than 7.15% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$5.93B | -1845.6% | -1861.4% | -2149.7% | -3303.3% | |
| Annual SG&A | $344.34M | – | +0.3% | +33.7% | +163.2% | |
| Quarterly SG&A | $75.36M | +1.2% | -7.8% | +2.7% | +46.2% | |
| Price | $19.99 | +72.3% | +28.7% | -47.1% | -87.4% | |
| TTM Operating Profit | -$140.82M | +6.2% | +21.0% | +12.4% | -54.9% | |
| TTM D&A | $42.28M | +3.7% | -5.7% | +32.7% | +157.0% | |
| TTM Revenue | $641.81M | -0.4% | +1.9% | +27.4% | +145.1% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$5.61B | N/A | -5.7% |
| 3Y | -$3.92B | N/A | -51.4% |
| 5Y | -$1.80B | N/A | -229.1% |
| All | $878.10M | N/A | -775.3% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$5.93B | N/A | at low |
| 3Y | -$5.93B | N/A | at low |
| 5Y | -$5.93B | N/A | at low |
| All | -$5.93B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of TXG?
As of today, TXG TTM SG&A is -$5.93B
What is TXG TTM SG&A most recent change?
TXG TTM SG&A was down -1.30% on September 30, 2025
What is 1-year change in TXG TTM SG&A?
TXG TTM SG&A is down -1861.41% year-over-year
How does TXG TTM SG&A rank versus sector peers?
TXG TTM SG&A is higher than 7.15% of companies in Healthcare sector
When is TXG next earnings release?
The next earnings release for TXG is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- TXG Official Website www.10xgenomics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1770787/000162828025050332/0001628280-25-050332-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000177078725000013/0001770787-25-000013-index.htm
- TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
- TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg